Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery India 2014

Drug Discovery India 2014 Agenda



Co-Located Conference Agendas

Indian Lab Automation | Drug Discovery India 2014 | Drug Metabolism & Discovery ADMET | 

Print Agenda

Thursday, 11 September 2014

08:00

Registration

09:15

Inauguration

09:20

Chairman's Welcome and Inaugural Talk

09:30

Renaissance in Pharmacognosy:The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America

10:15

Memento Presentation

10:25

Coffee Break and Networking in Exhibition Area

10:55

Asit ChakrabortiKeynote Presentation

Hall 1- Novel Anti-Inflammatory Scaffolds through Sustainable Chemistry
Asit Chakraborti, Professor and Head, National Institute of Pharmaceutical Education and Research, India

10:55

Jyoti ChattopadhyayaKeynote Presentation

Hall 2- Understanding the Principles for harnessing Key Phosphate Hydrolysis Step in DNA and RNA complexes with Enzymes.
Jyoti Chattopadhyaya, Professor, Uppsala University, Sweden

11:30

Hall 1- Novel Heterocyclic Construction Using N-Heterocyclic Carbene Organocatalysis
Akkattu Biju, Senior Scientist, National Chemical Laboratory, India

11:30

Hall 2- A Novel Approach to Rescue the Neurodegenerative Diseases with the Modified Peptides Derived from Neuron Specific Kinase (Cdk5)
Harish Pant, Senior Investigator, National Institute of Health, United States of America

12:00

Hall 1- DNA-Targeted Anticancer Agents: Molecular Design and their Synthesis
N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India

12:00

Hall 2- Chemical Biology Approaches for Target Identification in "Activity Based Proteomic Profiling" Session
Maria Costi, Professor, University of Modena and Reggio Emilia, Italy

12:30

Accelrys-BIOVIATechnology Spotlight:
Hall 2: Using Protein Design Tools to Guide Pharmacophore Generation and Screening
Anand Krishnamurthy, Senior Scientist, Accelrys-BIOVIA

12:30

Hall 1- Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India

12:45

Krishna BanaudhaKeynote Presentation

Hall 2: Integrative Medicine: A Roadmap of Epigenetic Modulation in Health, Diseases Prevention, and Cure
Krishna Banaudha, Associate Professor, The George Washington University, United States of America

13:00

Advanced Chemistry Development IncTechnology Spotlight:
Hall 1: Drug Discovery & Development: The dilemma of Investing in Software Solutions
K K Bhagchandani, Director, Advanced Chemistry Development Inc

13:15

Hall1: Lunch and Networing in the Exhibition Area

13:20

Hall 2- Rethinking Drug Discovery: Going-in for Signaling Pathways and Novel Chemical Space to Hunt for Next Generation Functional Small Molecules
Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences, India

13:50

Hall 2: Lunch and Networking in the Exhibition Area

14:15

Anamik ShahKeynote Presentation

Hall 1- Collaborative Drug Research in India: Opportunity and Challenges in Global Perspectives"
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

14:30

Hall 2- Drugs through Mimicking the Actions of Glycosaminoglycans - Anticoagulants, AntiEmphysema/COPD and Anti-Cancer Stem Cells
Umesh Desai, Professor, Virginia Commonwealth University, United States of America

14:50

Hall 1: Dundee, Drug Discovery Unit: Novel Targets and Small Molecule Inhibitors
Ian Gilbert, Head of Chemistry, University of Dundee, United Kingdom

15:00

Agilent TechnologiesTechnology Spotlight:
Hall 2: Maximising Value and Success with Automation
Lesley Schultz, Product Manager, Agilent Technologies

15:15

Hall 2-Special Lecture: Protein Ubiquitination Enzymes as Novel Cancer Therapeutic Targets
Amit Banerjee, Professor, Wayne State University , United States of America

15:20

Hall 1: Coffee Break and Networking in Exhibition Area

15:40

G SastryKeynote Presentation

Hall 1- Modeling Specificity in Lead Optimization
G Sastry, Scientist and Head, Indian Institute of Chemical Technology, India

16:15

Hall 1- Open-Source Chemoinformatics for virtual screening in Drug Discovery
Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory, India

16:15

Hall 2- Advances in Developing Tankyrase Selective Inhibitors
Stefan Krauss, Director, University Of Oslo, Norway

16:45

Hall 1- Pharmacophore Modeling and Molecular Docking Based Thriving Protocol for Target Identification
Vijay Masand, Assistant Professor, Vidya Bharti College, India

16:45

Hall 2- Molecular Methods that Enable Targeted Therapeutics and Precision Medicine
Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc, United States of America

17:15

End of First Day of Conference

17:30

FREE WORKSHOP: RNA Silencing in Drug Discovery- Challenges and Strategies

Friday, 12 September 2014

09:00

Ashok VaidyaKeynote Presentation

Hall 1- Reverse Pharmacology (RP) - a Paradigm Shift- for Drug Discovery and Development
Ashok Vaidya, Research Director, Kasturba Health Society, India

09:30

Hall 2- Plenary Talk: Bioprocessing of Human Pluripotent Stem Cells using CompacT SelecT Cell Culture Automation
Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, France

09:35

Hall 1- Special Lecture: Moving from Single Drug to Formulation Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India

10:00

Hall 2- Stem Cell Based Chip Platforms In Drug Discovery
Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd., India

10:05

Hall 1- Natural Products for Drug Discovery and Development: Inspiration from the “Ancient Wisdom of Mother Nature"
Mukund Chorghade, President & CSO, Chorghade Enterprises, United States of America

10:30

Tecan Trading AGTechnology Spotlight:
Hall 2: Fluent™ Laboratory Automation Solution for Cell-Based Assays
Roland Durner, Global Head of LSB Distributors, Tecan Trading AG

10:35

Hall 1:Coffee Break and Networking in Exhibition Area

10:45

Hall 2: Coffee Break and Networking in Exhibition Area

10:55

Hall 1- "NMITLI Arthritis Model" (Validating Ayurvedic Drugs for Global Use).
Arvind Chopra, Director and Chief Rheumatologist, Center for Rheumatic Diseases, India

11:05

Hall 2- Annotating Biological Activities Of Drugs, Natural Products, And Environmental Toxicants by FACTORIAL™ Pathway Profiling Assays
Sergei Makarov, Chief Executive Officer, Attagene Inc, United States of America

11:25

Hall 1- Natural Products as New Sources of Drug and Nutraceutical Discovery
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India

11:35

Hall 2- Cell Based Assays in Clinical Diagnostics: Applications to Neutralizing Antibody Assays, Pharmacogenomics, and Personalized Medicine
John Watson, Director, Promega Corporation, United States of America

11:55

Hall 1- Plenary Talk: High-throughput in vivo Vertebrate Screening: an Automation Point of View
Giancarlo Basile, Editor in Chief, Current Research in Drug Discovery, Italy

12:05

Hall 2- Optimisation of New Trypanosoma brucei Inhibitors
Raphael Rahmani, Research Fellow, Monash University, Australia

12:25

Hall 1- Discovery of Novel Compounds for the Treatment of Drug Resistant and Persistent Tuberculosis
Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute, India

12:35

Hall 2- Repositioning of Drugs-Structure-Based Approach towards Finding New Leads as Antileishmanial Agents
Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute, India

12:55

Hall 1- High Content Image- Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Multiple Highly Pathogenic RNA Viruses
Krishna Kota, Scientist, PerkinElmer, United States of America

13:05

Hall 2- Special Lecture: Natural Products Repurposing for Cancer Therapy
Petr Bartunek, Group Leader, Academy of Sciences of the Czech Republic, Czech Republic

13:25

Freeslate IncTechnology Spotlight:
Hall 1: Leveraging the Power of High Throughput Screening to Identify a Diastereomeric Salt for Chiral Resolution
David Yamane, Product Marketing Director, Freeslate Inc

13:40

Hall 2: Lunch and Networking in Exhibition Area

13:40

Hall 1:Lunch and Networking in the Exhibition Area

14:20

POSTER EVALUATION

14:40

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America

15:10

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc, India

15:40

Crowdsourcing Systems Level Platform for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India

16:00

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

16:20

Open Discussion on Open Source Drug Discovery

16:40

Coffee Break and Networking in Exhibition Area

16:55

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

17:30

End of the Conference


Add to Calendar ▼2014-09-11 00:00:052014-09-12 00:00:00Europe/LondonDrug Discovery India 2014Drug Discovery India 2014 in MumbaiMumbaiSELECTBIOenquiries@selectbiosciences.com